Investment Team

Mr. Brennan brings 25 years of experience serving in key executive roles across large and mid-sized global contract research organizations (CROs), including PharmaNet, InVentiv, and Navitas Life Sciences, as well as clinical trial enablement companies providing medical imaging, clinical trial management, and patient recruitment solutions, such as Bioclinica, and drug development companies including Quinnova Pharmaceuticals and NBTY, Inc.

For the past six years, Mr. Brennan served as the Chief Operating Officer of Allucent, where he was primarily responsible for growing the organization from a 250-person regional CRO into a 1,250-person, global, full-service CRO.

Mr. Brennan now serves as the Chief Executive Officer of Elite Clinical Network, where he leads the organization’s strategic direction and continued expansion.